484 related articles for article (PubMed ID: 31611130)
21. Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail.
Zhou H; Li X; Wang Y; Wang Z; Zhu J; Wang Z; Chen X
BMC Gastroenterol; 2022 Nov; 22(1):473. PubMed ID: 36402960
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
[TBL] [Abstract][Full Text] [Related]
23. Enhancing Mural Nodules in the Main Pancreatic Duct of Main and Mixed Types of Intraductal Papillary Mucinous Neoplasms: Does Size Matter in Malignancy Risk?
Chon HK; Song TJ; Yoo KH; Hwang JS; Kim MH; Choi EK; Kim TH
Gut Liver; 2023 Nov; 17(6):942-948. PubMed ID: 37317514
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution.
Hwang DW; Jang JY; Lee SE; Lim CS; Lee KU; Kim SW
Langenbecks Arch Surg; 2012 Jan; 397(1):93-102. PubMed ID: 20640860
[TBL] [Abstract][Full Text] [Related]
25. Invasive Intraductal Papillary Mucinous Neoplasms: CT Features of Colloid Carcinoma Versus Tubular Adenocarcinoma of the Pancreas.
Fouladi DF; Raman SP; Hruban RH; Fishman EK; Kawamoto S
AJR Am J Roentgenol; 2020 May; 214(5):1092-1100. PubMed ID: 32130045
[No Abstract] [Full Text] [Related]
26. Malignant potential and specific characteristics of pure main duct type intraductal papillary mucinous neoplasm.
Fujita Y; Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Ueno M; Hayami S; Kobayashi R; Yanagisawa A; Yamaue H
Eur J Surg Oncol; 2022 May; 48(5):1054-1061. PubMed ID: 34933794
[TBL] [Abstract][Full Text] [Related]
27. Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms.
Crippa S; Pergolini I; Rubini C; Castelli P; Partelli S; Zardini C; Marchesini G; Zamboni G; Falconi M
Surgery; 2016 Apr; 159(4):1041-9. PubMed ID: 26704784
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas.
Kobayashi N; Sugimori K; Shimamura T; Hosono K; Watanabe S; Kato S; Ueda M; Endo I; Inayama Y; Maeda S; Nakajima A; Kubota K
Pancreatology; 2012; 12(2):141-5. PubMed ID: 22487524
[TBL] [Abstract][Full Text] [Related]
30. Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential.
Ammori JB; Do RK; Brennan MF; D'Angelica MI; Dematteo RP; Fong Y; Jarnagin WR; Allen PJ
J Gastrointest Surg; 2014 May; 18(5):911-6. PubMed ID: 24448998
[TBL] [Abstract][Full Text] [Related]
31. Natural history of branch-duct intraductal papillary mucinous neoplasms of the pancreas: a case report.
Casadei R; Ricci C; D'Ambra M; Taffurelli G; Zingaretti CC; Pacilio CA; Calculli L; Pagano N; Minni F
JOP; 2014 Jul; 15(4):391-3. PubMed ID: 25076351
[TBL] [Abstract][Full Text] [Related]
32. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
[TBL] [Abstract][Full Text] [Related]
33. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
[TBL] [Abstract][Full Text] [Related]
34. Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinoma.
Amini N; Rezaee N; Habib JR; Blair A; Beckman RM; Manos L; Cameron JL; Hruban RH; Weiss MJ; Fishman EK; Zaheer A; Lafaro KJ; Burkhart RA; O'Broin Lennon AM; Burns WR; He J; Wolfgang CL
HPB (Oxford); 2021 Mar; 23(3):468-474. PubMed ID: 32912834
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic juice cytology as sensitive test for detecting pancreatic malignancy in intraductal papillary mucinous neoplasm of the pancreas without mural nodule.
Kawada N; Uehara H; Nagata S; Tomita Y; Nakamura H
Pancreatology; 2016; 16(5):853-8. PubMed ID: 27459913
[TBL] [Abstract][Full Text] [Related]
36. Tumor doubling time in two cases of main duct intraductal papillary-mucinous neoplasms of the pancreas.
Tanno S; Sasajima J; Koizumi K; Yanagawa N; Nakano Y; Osanai M; Mizukami Y; Fujii T; Obara T; Okumura T; Kohgo Y
Hepatogastroenterology; 2009; 56(94-95):1545-8. PubMed ID: 19950827
[TBL] [Abstract][Full Text] [Related]
37. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
[TBL] [Abstract][Full Text] [Related]
38. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules.
Ohno E; Hirooka Y; Itoh A; Ishigami M; Katano Y; Ohmiya N; Niwa Y; Goto H
Ann Surg; 2009 Apr; 249(4):628-34. PubMed ID: 19300203
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors for Progression or Malignancy in Main-Duct and Mixed-Type Intraductal Papillary Mucinous Neoplasm of the Pancreas.
Jang DK; Ryu JK; Chung KH; Lee BS; Park JK; Lee SH; Kim YT
Pancreas; 2016 Aug; 45(7):1027-31. PubMed ID: 26692447
[TBL] [Abstract][Full Text] [Related]
40. IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection.
Marchegiani G; Mino-Kenudson M; Sahora K; Morales-Oyarvide V; Thayer S; Ferrone C; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Ann Surg; 2015 May; 261(5):976-83. PubMed ID: 24979607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]